Transfection Reagents & Equipment Market - Global Forecast 2026-2032

The Transfection Reagents & Equipment Market is projected to reach USD 1.60 Billion in 2026. It is expected to continue growing at a CAGR of 7.18%, reaching USD 2.43 Billion by 2032.

The transfection reagents and equipment landscape is central to modern life sciences because it enables nucleic acids, proteins, and gene-editing systems to enter cells for discovery, biomanufacturing, and therapeutic development. Demand is supported by sustained scientific activity in cell and gene therapy, RNA therapeutics, vaccine research, oncology, immunology, and functional genomics, where reproducible delivery into primary cells, stem cells, immune cells, and difficult-to-transfect cell lines remains a critical workflow requirement.

Market momentum is reinforced by the clinical validation of nucleic acid-based medicine. Regulatory approvals for mRNA vaccines, CAR-T therapies, adeno-associated virus gene therapies, and the first CRISPR-based therapy approvals in major markets have increased the need for reliable transfection technologies across research, process development, and quality-controlled manufacturing environments. As a result, suppliers are differentiating through higher cell viability, lower cytotoxicity, scalable electroporation platforms, animal-origin-free chemistries, closed-system compatibility, and application-specific protocols for cell therapy, biologics, and synthetic biology workflows.

Transformative Shifts in the Landscape

The transfection reagents and equipment market is shifting from general-purpose laboratory transfection toward application-specific, scalable, and regulatory-aligned delivery solutions. Lipid-based transfection reagents remain widely used for plasmid DNA, siRNA, mRNA, and protein-expression workflows, while electroporation and nucleofection continue gaining relevance for primary cells, T cells, natural killer cells, induced pluripotent stem cells, and other hard-to-transfect systems. This shift reflects the industry’s need to balance transfection efficiency with cell viability, phenotype preservation, and downstream functionality.

Another transformative change is the convergence of research tools with manufacturing-ready transfection platforms. Cell therapy developers increasingly require closed, automated, and GMP-compatible delivery systems that reduce contamination risk and operator variability. At the same time, academic and contract research laboratories are prioritizing workflow simplicity, data reproducibility, and reagent consistency as high-throughput screening, CRISPR knockout libraries, transient protein production, and viral vector development expand across translational research programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing transfection workflows by improving experimental design, protocol optimization, and quality prediction. Machine learning models can analyze cell type, nucleic acid payload, reagent ratio, pulse parameters, viability readouts, and expression outcomes to recommend optimized conditions faster than traditional trial-and-error approaches. This is particularly valuable for primary cells, immune cells, stem cells, and patient-derived samples, where limited material availability makes experimental efficiency commercially and clinically important.

AI also supports supplier competitiveness by accelerating formulation development, enabling predictive maintenance for electroporation instruments, improving automated image-based assessment of transfection efficiency, and strengthening digital quality control in cell processing workflows. As laboratories connect instruments, laboratory information management systems, electronic lab notebooks, and imaging platforms, AI-enabled analytics can reduce variability, improve documentation, and support more reproducible transfection outcomes in regulated and non-regulated environments.

Key Regional Insights

Asia-Pacific is becoming a major hub for transfection reagents and equipment as China, Japan, South Korea, India, Australia, and ASEAN markets expand investments in biotechnology, vaccine platforms, biologics, genomics, and cell therapy research. China’s large biopharma base and active clinical research environment support demand for scalable nucleic acid delivery tools, while Japan and South Korea’s advanced life sciences infrastructure favor premium reagents, precision instruments, and regenerative medicine workflows. India is strengthening cost-efficient research, biologics production, and contract development capabilities, and Australia supports clinical translation through strong biomedical research networks and regulated advanced therapy programs. Across Southeast Asia, growing public and private investment in life sciences is improving access to molecular biology platforms and training-driven adoption.

North America remains a leading center of adoption, anchored by the United States and Canada’s concentration of pharmaceutical research, academic medical centers, NIH-supported biomedical science, clinical-stage cell and gene therapy developers, and specialized contract development and manufacturing organizations. Europe benefits from strong research networks, the European Medicines Agency framework, and established life science clusters in Germany, France, the United Kingdom, Italy, Spain, and the Nordics, with demand shaped by advanced therapy development, biomanufacturing standards, and cross-border research collaboration. Latin America, led by Brazil and Mexico, is showing gradual uptake through academic research, biosimilar development, vaccine capabilities, and public health biotechnology initiatives. The Middle East, especially GCC countries, is investing in genomics, precision medicine, and national biotechnology strategies, while Africa’s opportunity is linked to expanding molecular biology capacity, vaccine research partnerships, genomic surveillance, and public health laboratories.

Key Group Insights

ASEAN is gaining relevance as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines expand biomedical research infrastructure, with Singapore serving as a regional anchor for translational science, clinical research, and bioprocessing. Demand across ASEAN is supported by rising investment in university laboratories, diagnostic modernization, vaccine research, and regional contract research capabilities. The GCC is building demand through healthcare diversification, genomics programs, precision medicine initiatives, and national science strategies in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets, where imported high-performance platforms are often favored for advanced research environments.

The European Union provides a large, regulation-driven environment for transfection technologies through coordinated research funding, cross-border clinical development, advanced therapy medicinal product regulation, and strong biomanufacturing standards. BRICS economies are important for volume growth because Brazil, Russia, India, China, and South Africa combine large patient populations, expanding domestic biotechnology, and growing research capacity, although procurement models, regulatory alignment, and supply chain access vary by country. The G7 remains a premium demand center due to advanced pharmaceutical R&D, deep venture funding, established academic ecosystems, and mature clinical translation infrastructure. NATO-aligned countries add resilience through investments in biosecurity, pandemic preparedness, medical countermeasures, and dual-use biotechnology infrastructure, all of which require reliable nucleic acid delivery workflows.

Key Country Insights

The United States leads demand through its concentration of cell and gene therapy developers, leading universities, life science tool users, and FDA-regulated clinical translation pathways, supported by extensive public and private biomedical research. Canada contributes through strong academic research, regenerative medicine networks, and clinical manufacturing initiatives, while Mexico is building capabilities in biomedical research, pharmaceutical production, and nearshore life science supply chains. Brazil is the primary Latin American opportunity due to its large healthcare system, public research institutions, vaccine capabilities, and biologics infrastructure.

In Europe, the United Kingdom remains influential in genomics, advanced therapies, and academic spinouts; Germany combines engineering strength with biopharma manufacturing and precision instrumentation adoption; France supports immunology, oncology, vaccine, and cell therapy research; Italy and Spain contribute through translational medicine networks, hospital-based research, and growing advanced therapy capabilities; and Russia maintains scientific capability despite geopolitical and supply chain constraints that affect access to specialized reagents and equipment. In Asia-Pacific, China is scaling rapidly in biopharma, gene editing, and cell therapy; India is expanding cost-competitive research, biosimilars, vaccines, and biologics production; Japan emphasizes high-quality regenerative medicine, iPSC research, and precision tools; Australia supports clinical translation, biomedical research, and early-phase advanced therapy studies; and South Korea is advancing cell therapy, biologics, vaccine platforms, and contract development capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize application-specific portfolios that address distinct workflows for mRNA delivery, CRISPR editing, transient protein expression, viral vector production, and immune cell engineering. Competitive advantage will come from validated protocols, high-viability performance in difficult cell types, GMP-compatible documentation, lot-to-lot consistency, and systems that move smoothly from discovery to process development and clinical manufacturing.

Companies should also invest in automation, closed-system compatibility, digital protocol libraries, and AI-enabled optimization tools that reduce user variability. Regional strategies should combine premium platforms for North America, Europe, Japan, and South Korea with cost-effective, training-supported offerings for India, Southeast Asia, Latin America, the Middle East, and Africa. Partnerships with contract development and manufacturing organizations, academic core facilities, hospitals, and cell therapy centers can accelerate adoption and generate application data that strengthens technical credibility.

Research Methodology

This executive summary is developed through a structured secondary research approach aligned with market intelligence best practices. The analysis considers publicly available regulatory records, scientific literature, clinical trial activity, government biotechnology initiatives, documented life science funding programs, and adoption patterns across research, therapeutic development, and biomanufacturing workflows.

Insights are validated by triangulating demand signals from peer-reviewed research activity, clinical approvals in nucleic acid and cell-based therapies, regional biotechnology investments, and innovation in lipid reagents, polymer-based reagents, electroporation, nucleofection, and automated transfection systems. The methodology emphasizes evidence-based interpretation rather than speculative market sizing, ensuring that conclusions remain grounded in observable industry developments and verifiable technology adoption trends.

Conclusion

Transfection reagents and equipment are no longer limited to routine laboratory support; they are enabling technologies for genetic medicine, cell therapy, synthetic biology, protein production, viral vector development, and advanced disease modeling. As therapeutic modalities become more complex and cell types more specialized, the landscape is moving toward precision delivery, reproducibility, scalability, automation, and regulatory readiness.

Suppliers that combine high-performance chemistries, robust electroporation platforms, AI-guided optimization, GMP-aligned workflows, and regionally tailored commercial strategies will be best positioned to address evolving demand. The strongest opportunities will emerge where scientific validation, manufacturing scalability, workflow integration, and reliable technical support converge across global life science ecosystems.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transfection Reagents & Equipment Market, by Product Type

7.1. Introduction
7.2. Transfection Reagents
7.2.1. Lipid-based Transfection Reagents
7.2.2. Polymer-Based Reagents
7.2.3. Calcium Phosphate Reagents
7.3. Transfection Equipment
7.3.1. Electroporation Systems
7.3.2. Microinjection Systems

8. Transfection Reagents & Equipment Market, by Technology Type

8.1. Introduction
8.2. Chemical Methods
8.3. Physical Methods
8.4. Viral Methods

9. Transfection Reagents & Equipment Market, by Molecule Type

9.1. Introduction
9.2. Plasmid DNA
9.3. shRNA
9.4. mRNA
9.5. CRISPR-Cas9 RNP complexes
9.6. Oligonucleotides

10. Transfection Reagents & Equipment Market, by Transfection Mode

10.1. Introduction
10.2. Transient Transfection
10.3. Stable Transfection
10.4. Episomal Expression Systems

11. Transfection Reagents & Equipment Market, by Application

11.1. Introduction
11.2. Gene Expression Studies
11.3. Protein Production
11.4. Drug Discovery & Development
11.5. Gene Therapy & Cell Therapy
11.6. Vaccine Development

12. Transfection Reagents & Equipment Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Transfection Reagents & Equipment Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Transfection Reagents & Equipment Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Agilent Technologies, Inc.
16.2. Altogen Biosystems
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. Bio-Techne Corporation
16.6. Biontex Laboratories GmbH
16.7. Celetrix LLC
16.8. GeneCopoeia Inc.
16.9. Lonza Group AG
16.10. MaxCyte, Inc.
16.11. Merck KGaA
16.12. Mirus Bio LLC
16.13. Novogene Corporation
16.14. OriGene Technologies, Inc.
16.15. Polyplus-transfection SA
16.16. Promega Corporation
16.17. QIAGEN N.V.
16.18. Revvity
16.19. Roche Holding AG
16.20. Sartorius AG
16.21. SignaGen Laboratories
16.22. Takara Bio Inc.
16.23. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LIPID-BASED TRANSFECTION REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL POLYMER-BASED REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CALCIUM PHOSPHATE REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSFECTION EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CHEMICAL METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CHEMICAL METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CHEMICAL METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PHYSICAL METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PHYSICAL METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PHYSICAL METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL VIRAL METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL VIRAL METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL VIRAL METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PLASMID DNA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PLASMID DNA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PLASMID DNA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SHRNA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SHRNA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SHRNA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MRNA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MRNA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MRNA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CRISPR-CAS9 RNP COMPLEXES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSIENT TRANSFECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL STABLE TRANSFECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL EPISOMAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PROTEIN PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL GENE THERAPY & CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 105. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 106. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 107. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 108. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 109. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 121. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 122. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 123. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 124. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 125. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 130. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 131. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 132. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 134. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 138. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 139. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 140. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 141. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 142. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 154. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 155. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 156. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 157. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 158. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 162. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 163. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 164. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 165. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 166. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 170. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 171. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 172. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 173. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 174. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 176. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 177. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 179. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 180. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 181. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 183. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 185. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 187. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 188. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 189. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 190. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 191. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 195. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 196. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 197. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 198. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 199. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 202. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 203. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 204. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 205. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 206. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 207. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 219. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 220. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 221. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 222. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 223. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 227. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 228. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 229. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 230. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 231. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 235. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 236. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 237. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 238. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 239. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 243. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 244. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 245. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 246. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 247. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 251. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 252. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 253. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 254. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 255. SPAIN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 259. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 260. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 261. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 262. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 263. CHINA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 267. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 268. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 269. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 270. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 271. INDIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 275. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 276. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 277. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 278. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 279. JAPAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 283. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 284. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 285. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 286. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 287. AUSTRALIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION REAGENTS, 2017-2032 (USD MILLION)
TABLE 291. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 292. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 293. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 294. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY TRANSFECTION MODE, 2017-2032 (USD MILLION)
TABLE 295. SOUTH KOREA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 297. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

Agilent Technologies, Inc.
Altogen Biosystems
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Biontex Laboratories GmbH
Celetrix LLC
GeneCopoeia Inc.
Lonza Group AG
MaxCyte, Inc.
Merck KGaA
Mirus Bio LLC
Novogene Corporation
OriGene Technologies, Inc.
Polyplus-transfection SA
Promega Corporation
QIAGEN N.V.
Revvity
Roche Holding AG
Sartorius AG
SignaGen Laboratories
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	185
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.6 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.43 Billion
Compound Annual Growth Rate	7.1%
Regions Covered	Global
No. of Companies Mentioned	24

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Transfection Technologies Market - Global Forecast 2026-2032

Transfection Reagents and Equipment - Global Strategic Business Report

Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035

Transfection Technologies - Global Strategic Business Report

Transfection Reagents and Equipment Market Report 2026